An in vitro study found that inhibition of Heat Shock Protein 90 (Hsp90) via a targeted agent had a significant radiosensitizing effect on Gefinitib-resistant, EGFR-mutant NSCLC cell lines [40]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.